Fortrea Grows Its Non-Commercial Specialty Pharma Offering
The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.
Fortrea, a contract research organization (CRO), has opened its newly expanded 40,000 square-foot, non-commercial specialty pharmacy, FortreaRx, in Lake Mary, Fla., which is expected to provide various forms of patient access solutions—along with ambient and cold-chain distribution services—across the United States.
The specialty pharmacy is licensed in all 50 states and US territories; its goal is to act as a link between pharmaceutical manufacturers and patients who qualify for the prescription assistant requirements set by manufacturers, which are also known as patient assistance programs. Its call center hub of case managers is able to help with these types of matters.
FortreaRx’s expansion project not only doubles the amount of available operational space, but also boosts its services, with the ability to now provide:
- 1,800 square feet of ambient storage
- More processing and fulfillment space for up to 18,000 prescriptions daily
- Over 6,000 square feet of cold chain storage with more than 85% of prescriptions filled by FortreaRx
- A plethora of shipping options, including overnight, expedited, and 2-day deliveries
"Fortrea’s well-established patient services offerings, combined with the expanded capabilities of FortreaRx, deliver an end-to-end approach, from early clinical stages to post-market delivery, ensuring a comprehensive and personalized experience for patients," said Bill Nolan, Fortrea’s VP and global head of patient access. "From our expertise in broad-range disease states to our unwavering commitment to patient assistance, Fortrea excels at delivering timely and impactful solutions to our pharmaceutical sponsors that strive to reduce patient and provider challenges by streamlining enrollment processes and by offering full integration with broader patient support initiatives."
Reference
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx Expansion. Fortrea. News release. February 20, 2024. Accessed February 23, 2024. https://ir.fortrea.com/news-releases/news-release-details/fortrea-increases-patient-access-capabilities-and-cold-chain
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.
